Pentoxifylline-augmented antiproliferative effects of adrenomedullin on vascular smooth muscle cells.
Laboratory of Intensive Care Medicine, Division of General Internal Medicine, Department of Internal Medicine, University of Innsbruck, Anichstrasse 35, A-6020, Innsbruck, Austria.
S
S
Dunzendorfer
C
C
Meierhofer
Q
Q
Xu
C J
CJ
Wiedermann
D053607:Adrenomedullin; D000818:Animals; D001011:Aorta / Q000166:cytology; D003994:Bucladesine / Q000494:pharmacology; D015740:Calcitonin Gene-Related Peptide / Q000494:pharmacology; D000077221:Calcitonin Gene-Related Peptide Receptor Antagonists; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000378:metabolism; D007424:Intracellular Fluid / Q000378:metabolism; D008916:Miotics / Q000494:pharmacology; D009131:Muscle, Smooth, Vascular / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D010431:Pentoxifylline / Q000494:pharmacology*; D010446:Peptide Fragments / Q000494:pharmacology; D010455:Peptides / Q000819:agonists* / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D014665:Vasodilator Agents / Q000494:pharmacology*
D000077221:Calcitonin Gene-Related Peptide Receptor Antagonists; D008916:Miotics; D010446:Peptide Fragments; D010455:Peptides; D014665:Vasodilator Agents; C058636:calcitonin gene-related peptide (8-37); D053607:Adrenomedullin; D003994:Bucladesine; D000242:Cyclic AMP; D015740:Calcitonin Gene-Related Peptide; D010431:Pentoxifylline